Quick Answer
Curanex Pharmaceuticals Inc reported Net Income of -$4.23 million for fiscal year 2025.
Curanex Pharmaceuticals Inc Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$4.23M | -1068.8% |
| 2024 | -$361.5K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$954.1K | -946.5% | -1481.0% |
| June 30, 2025 | -$60.3K | -36.5% | +56.1% |
| March 31, 2025 | -$137.6K | -71.5% | -50.9% |
| September 30, 2024 | -$91.2K | — | -106.3% |
| June 30, 2024 | -$44.2K | — | +44.9% |
| March 31, 2024 | -$80.2K | — | — |
- Curanex Pharmaceuticals Inc showed a decrease of -1068.8% in Net Income compared to the prior fiscal year.
- Over the 2024–2025 period, Curanex Pharmaceuticals Inc’s net income has declined by 1068.8% (from -$361.5 thousand to -$4.23 million).
- The most recent figure is from Curanex Pharmaceuticals Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: